







































Emmanuel Ifeanyi Obeagu                                                                                                          Asian Journal of Dental and Health Sciences. 2025; 5(1):1-4 

[1]                                                                                                                                                                                                                                              AJDHS.COM 

 

 

Available online at ajdhs.com 

Asian Journal of Dental and Health Sciences 
Open Access to Dental and Medical Research 

Copyright  © 2025 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 
which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the 

original author and source are credited  

 

 

Using Mentzer Index to Improve Anemia Management in Pregnancy: A 
Narrative Review 

Emmanuel Ifeanyi Obeagu *  

Department of Biomedical and Laboratory Science, Africa University, Zimbabwe 

Article Info: 
_____________________________________________ 
Article History: 

Received   02 Nov 2024     
Reviewed  11 Dec 2024 
Accepted   09 Jan 2025 
Published 15 March 2025 

_____________________________________________ 
Cite this article as:  

Obeagu EI, Using Mentzer Index to Improve 
Anemia Management in Pregnancy: A 
Narrative Review, Asian Journal of Dental and 
Health Sciences. 2025; 5(1):1-4                                                                     

DOI: http://dx.doi.org/10.22270/ajdhs.v5i1.106         

Abstract 
_________________________________________________________________________________________________________________ 

Anemia during pregnancy is a significant public health challenge, affecting maternal well-being and 
fetal development. Among the most common causes are iron deficiency anemia (IDA) and 
thalassemia trait (TT), conditions requiring distinct management strategies. Accurate differentiation 
between these conditions is critical, as misdiagnosis can lead to suboptimal treatment outcomes. The 
Mentzer Index, calculated by dividing the mean corpuscular volume (MCV) by the red blood cell 
(RBC) count, offers a simple and reliable tool for distinguishing between IDA and TT, especially in 
resource-limited settings. This review explores the utility of the Mentzer Index in improving anemia 
diagnosis and management in pregnancy. By analyzing routine complete blood count (CBC) results, 
the Mentzer Index allows for initial differentiation, facilitating timely and appropriate interventions. 
A Mentzer Index value of ≥13 indicates IDA, guiding clinicians toward iron supplementation, while a 
value <13 suggests TT, prompting further investigations and genetic counseling. This approach 
reduces unnecessary interventions, improves diagnostic accuracy, and ensures tailored 
management, mitigating complications such as preterm birth, low birth weight, and maternal 
morbidity. 

Keywords: Mentzer Index, pregnancy, anemia, iron deficiency, thalassemia 

*Address for Correspondence:   

Emmanuel Ifeanyi Obeagu, Department of Biomedical and Laboratory Science, Africa University, Zimbabwe 

 

Introduction 

Anemia in pregnancy is a global health concern, 
particularly in low- and middle-income countries, where 
it affects nearly 40% of pregnant women. This condition 
is associated with significant maternal and fetal 
complications, including maternal fatigue, increased risk 
of infections, preterm birth, low birth weight, and 
perinatal mortality. Anemia during pregnancy is a 
multifactorial condition, with iron deficiency anemia 
(IDA) and thalassemia trait (TT) representing the most 
common etiologies. Accurate differentiation between 
these two types of anemia is critical, as their 
management strategies differ significantly, and 
misdiagnosis can exacerbate complications or lead to 
unnecessary interventions.1-3 Iron deficiency anemia 
(IDA) is the most prevalent form of anemia worldwide, 
characterized by reduced red blood cell production due 
to insufficient iron availability. IDA commonly results 
from increased iron demands during pregnancy, 
coupled with inadequate dietary intake or chronic blood 
loss. In contrast, thalassemia trait (TT) is a genetic 
condition associated with impaired hemoglobin 
production, resulting in microcytosis and hypochromia. 
While IDA typically responds well to iron 
supplementation, the treatment for TT is more complex, 
involving genetic counseling, prenatal screening, and 

the prevention of unnecessary iron overload. Therefore, 
distinguishing between IDA and TT is essential for 
effective patient management.4-6 The Mentzer Index has 
emerged as a practical tool for differentiating between 
IDA and TT in clinical practice. Calculated by dividing 
the mean corpuscular volume (MCV) by the red blood 
cell (RBC) count, this index provides a simple and cost-
effective method for initial screening. A Mentzer Index 
value of ≥13 is indicative of IDA, while a value <13 
suggests TT. Its reliance on parameters obtained from 
routine complete blood count (CBC) tests makes it an 
accessible and low-cost option, especially in resource-
constrained settings where advanced diagnostic tools 
such as hemoglobin electrophoresis or genetic testing 
may not be readily available.7 In addition to its 
practicality, the Mentzer Index addresses several 
challenges associated with anemia diagnosis in 
pregnancy. It helps reduce diagnostic delays, enabling 
timely and appropriate interventions. Early 
differentiation between IDA and TT prevents 
complications arising from mistreatment, such as the 
risk of iron overload in patients with TT who are 
mistakenly prescribed iron supplements. Furthermore, 
the Mentzer Index supports informed decision-making 
in antenatal care, allowing clinicians to implement 
tailored interventions that align with the underlying 
cause of anemia.8 

                     Open Access                                                                                                                                                                                                                Review Article                                                                           

http://jddtonline.info/
http://dx.doi.org/10.22270/ajdhs.v5i1.106
https://crossmark.crossref.org/dialog/?doi=10.22270/ajdhs.v5i1.106&amp;domain=pdf
https://orcid.org/0000-0002-4538-0161


Emmanuel Ifeanyi Obeagu                                                                                                          Asian Journal of Dental and Health Sciences. 2025; 5(1):1-4 

[2]                                                                                                                                                                                                                                              AJDHS.COM 

The Role of the Mentzer Index in Anemia 
Diagnosis 

Calculation and Interpretation 

The Mentzer Index is a simple mathematical calculation 
derived from routine complete blood count (CBC) 
results. It is obtained by dividing the mean corpuscular 
volume (MCV) by the red blood cell (RBC) count, 
expressed in millions per microliter (µL). This 
calculation provides a numerical value that aids in 
distinguishing between iron deficiency anemia (IDA) 
and thalassemia trait (TT), two common causes of 
anemia. A Mentzer Index value of ≥13 suggests IDA, as 
this condition is typically associated with low MCV and 
RBC count. Conversely, a value <13 is indicative of TT, 
characterized by low MCV but a normal or elevated RBC 
count.9 The accessibility of the Mentzer Index lies in its 
simplicity and reliance on routinely performed CBC 
tests. This makes it an attractive tool in resource-limited 
settings where advanced diagnostic techniques such as 
hemoglobin electrophoresis or genetic testing are often 
unavailable. Additionally, its non-invasive nature and 
ease of calculation enable widespread adoption, even in 
primary care settings.10 

Application in Pregnancy 

During pregnancy, anemia is frequently encountered 
and can have profound consequences for both mother 
and child. The Mentzer Index serves as a valuable tool in 
differentiating between IDA and TT, aiding clinicians in 
making informed treatment decisions. In cases of IDA, 
elevated Mentzer Index values direct healthcare 
providers toward iron supplementation, addressing the 
underlying deficiency. For TT, a low Mentzer Index 
value highlights the need for genetic counseling and 
avoidance of unnecessary iron supplementation, which 
could lead to iron overload.11 

Benefits in Clinical Practice 

Incorporating the Mentzer Index into anemia diagnosis 
during pregnancy offers multiple benefits. It facilitates 
early differentiation between IDA and TT, reducing 
delays in initiating appropriate therapy. This is 
particularly important in pregnancy, where untreated 
anemia can lead to adverse outcomes such as preterm 
delivery, intrauterine growth restriction, and increased 
maternal morbidity. Furthermore, the Mentzer Index 
minimizes the risk of over-treatment, ensuring that iron 
supplementation is reserved for those who will benefit 
from it, while patients with TT receive appropriate 
genetic evaluation and counseling.12 

Implications for Anemia Management 

Tailored Treatment Approaches 

The use of the Mentzer Index in anemia diagnosis allows 
for tailored treatment strategies that address the 
specific underlying cause of anemia in pregnant women. 
In cases of iron deficiency anemia (IDA), characterized 
by a Mentzer Index value of ≥13, treatment focuses on 
iron supplementation. This approach replenishes iron 
stores, improves hemoglobin levels, and reduces 
symptoms such as fatigue and dizziness, which can 

impact maternal quality of life and fetal growth. In 
contrast, a Mentzer Index value <13, indicative of 
thalassemia trait (TT), highlights the importance of 
avoiding unnecessary iron supplementation, which 
could lead to iron overload and associated 
complications. Instead, patients with TT benefit from 
genetic counseling and prenatal screening to assess the 
risk of severe hemoglobinopathies in the fetus.13 

Reducing Diagnostic Delays 

Anemia during pregnancy is associated with significant 
maternal and fetal risks, including preterm birth, low 
birth weight, and increased perinatal mortality. The 
Mentzer Index facilitates early differentiation between 
IDA and TT, enabling clinicians to initiate appropriate 
management promptly. This reduces delays caused by 
waiting for confirmatory tests and helps mitigate 
complications that arise from untreated anemia. 
Moreover, the ability to distinguish anemia types using a 
simple, accessible tool ensures timely interventions, 
particularly in resource-constrained settings where 
diagnostic resources may be limited.14 

Enhancing Cost-Effectiveness 

In regions with limited healthcare infrastructure, 
advanced diagnostic tools such as hemoglobin 
electrophoresis or genetic testing may be unavailable or 
unaffordable. The Mentzer Index offers a cost-effective 
alternative for initial screening. Its reliance on routinely 
available complete blood count (CBC) parameters 
makes it accessible to a broader population, reducing 
financial barriers to care. By identifying patients who 
require confirmatory testing or specific interventions, 
the Mentzer Index helps allocate healthcare resources 
more efficiently, ensuring that advanced diagnostic 
services are reserved for cases where they are most 
needed.15 

Supporting Comprehensive Care 

Incorporating the Mentzer Index into anemia 
management during pregnancy aligns with the 
principles of comprehensive antenatal care. It facilitates 
a holistic approach to maternal health by combining 
initial screening with confirmatory tests and lifestyle 
interventions. For IDA, this may include dietary 
counseling to improve iron intake and addressing 
contributing factors such as gastrointestinal blood loss. 
For TT, the focus shifts to genetic counseling, family 
planning, and monitoring fetal hemoglobin status. By 
addressing the root causes of anemia, the Mentzer Index 
contributes to sustainable improvements in maternal 
and fetal outcomes.16 

Implications for Public Health 

Widespread adoption of the Mentzer Index can 
significantly impact public health, particularly in low- 
and middle-income countries where anemia prevalence 
is high. Its use as a routine screening tool in antenatal 
care programs can help identify anemia cases early, 
ensuring that interventions are initiated before 
complications arise. Additionally, its simplicity and 
accessibility make it an ideal candidate for training 
healthcare workers in primary care settings, 



Emmanuel Ifeanyi Obeagu                                                                                                          Asian Journal of Dental and Health Sciences. 2025; 5(1):1-4 

[3]                                                                                                                                                                                                                                              AJDHS.COM 

empowering them to provide effective maternal care 
and improve community health outcomes.17 

Challenges and Limitations 

Diagnostic Ambiguity in Mixed Anemia 

One of the primary limitations of the Mentzer Index is 
its inability to accurately diagnose mixed anemia, where 
iron deficiency anemia (IDA) coexists with thalassemia 
trait (TT). In such cases, the red blood cell (RBC) count 
and mean corpuscular volume (MCV) values may not 
clearly align with the expected ranges for IDA or TT, 
leading to intermediate or misleading Mentzer Index 
values. This ambiguity can complicate the diagnostic 
process, necessitating further confirmatory testing, such 
as serum ferritin measurements or hemoglobin 
electrophoresis, to determine the precise etiology of 
anemia.18 

Influence of Concurrent Conditions 

The accuracy of the Mentzer Index can be influenced by 
concurrent medical conditions that affect RBC 
parameters. Chronic infections, inflammation, or other 
underlying diseases can alter the MCV or RBC count, 
potentially skewing the index value. For example, in 
inflammatory states, changes in iron metabolism may 
mask or mimic the characteristics of IDA. These factors 
can limit the reliability of the Mentzer Index, 
particularly in pregnant women with multiple 
comorbidities, underscoring the need for 
comprehensive clinical evaluation and additional 
diagnostic tools.19-20 

Limited Scope as a Screening Tool 

While the Mentzer Index is a valuable screening tool, it 
is not a definitive diagnostic method. Its simplicity, 
though advantageous, also restricts its ability to capture 
the complexity of anemia pathophysiology. For example, 
the index does not differentiate between different forms 
of thalassemia or detect other less common causes of 
anemia, such as vitamin B12 or folate deficiencies. Its 
use is therefore limited to preliminary differentiation 
between IDA and TT, necessitating further 
investigations to confirm the diagnosis and guide 
treatment.21-22 

Challenges in Low-Resource Settings 

Although the Mentzer Index is cost-effective and 
accessible, its reliance on accurate and high-quality 
complete blood count (CBC) results can pose challenges 
in low-resource settings. Poorly calibrated laboratory 
equipment or lack of trained personnel may 
compromise the reliability of the RBC count and MCV 
values, leading to erroneous index calculations. 
Additionally, the unavailability of follow-up 
confirmatory tests, such as ferritin assays or 
hemoglobin electrophoresis, may hinder the effective 
use of the Mentzer Index in guiding treatment 
decisions.23-24 

Risk of Over-Reliance 

Over-reliance on the Mentzer Index without 
confirmatory testing can lead to misdiagnosis and 

inappropriate management. For instance, patients with 
a falsely elevated index value may be misclassified as 
having IDA and treated with unnecessary iron 
supplementation, potentially resulting in iron overload 
in those with TT. Conversely, underestimating the 
complexity of anemia in patients with mixed etiologies 
could delay appropriate interventions, increasing the 
risk of maternal and fetal complications.25-26 

Need for Training and Awareness 

The successful application of the Mentzer Index in 
clinical practice requires adequate training of 
healthcare providers. Misinterpretation of the index or 
lack of awareness about its limitations can reduce its 
diagnostic utility. Educational initiatives are essential to 
ensure that clinicians understand when and how to use 
the Mentzer Index effectively, as well as the importance 
of complementing it with additional diagnostic 
methods.27 

Conclusion 

The Mentzer Index serves as a valuable and accessible 
tool for the initial evaluation of anemia during 
pregnancy, offering a simple and cost-effective method 
to differentiate between iron deficiency anemia (IDA) 
and thalassemia trait (TT). Its reliance on routinely 
performed complete blood count (CBC) parameters 
makes it particularly advantageous in resource-limited 
settings where advanced diagnostic facilities are 
unavailable. By enabling timely and accurate 
identification of the anemia type, the Mentzer Index 
facilitates targeted interventions that improve maternal 
and fetal health outcomes. However, the Mentzer Index 
is not without its challenges. Its diagnostic accuracy can 
be affected by mixed anemia, concurrent medical 
conditions, and limitations inherent to the index itself, 
such as its inability to differentiate between all forms of 
anemia. Over-reliance on the index without 
confirmatory testing risks misdiagnosis and 
inappropriate management. Therefore, its application 
should be complemented by additional diagnostic tests, 
including serum ferritin measurements, hemoglobin 
electrophoresis, and genetic counseling when necessary. 

Conflict of Interest: Author declares no potential 

conflict of interest with respect to the contents, 

authorship, and/or publication of this article. 

Source of Support: Nil 

Funding: The authors declared that this study has 

received no financial support. 

Informed Consent Statement: Not applicable.  

Data Availability Statement: The data supporting in 

this paper are available in the cited references.  

Ethics approval: Not applicable. 

References 

1. Rahman MM, Abe SK, Rahman MS, Kanda M, Narita S, Bilano V, Ota 
E, Gilmour S, Shibuya K. Maternal anemia and risk of adverse birth 
and health outcomes in low-and middle-income countries: 
systematic review and meta-analysis. The American journal of 



Emmanuel Ifeanyi Obeagu                                                                                                          Asian Journal of Dental and Health Sciences. 2025; 5(1):1-4 

[4]                                                                                                                                                                                                                                              AJDHS.COM 

clinical nutrition. 2016; 103(2):495-504. 
https://doi.org/10.3945/ajcn.115.107896 PMid:26739036 

2. Obeagu EI, Ezimah AC, Obeagu GU. Erythropoietin in the anaemias 
of pregnancy: a review. Int J Curr Res Chem Pharm Sci. 
2016;3(3):10-18. https://doi.org/10.22270/ijmspr.v10i2.95 

3. Okamgba OC, Nwosu DC, Nwobodo EI, Agu GC, Ozims SJ, Obeagu EI, 
Ibanga IE, Obioma-Elemba IE, Ihekaire DE, Obasi CC, Amah HC. 
Iron Status of Pregnant and Post-Partum Women with Malaria 
Parasitaemia in Aba Abia State, Nigeria. Annals of Clinical and 
Laboratory Research. 2017;5(4):206. 

4. Petrakos G, Andriopoulos P, Tsironi M. Pregnancy in women with 
thalassemia: challenges and solutions. International journal of 
women's health. 2016:441-451. 
https://doi.org/10.2147/IJWH.S89308 PMid:27660493 
PMCid:PMC5019437 

5. Obeagu EI, Adepoju OJ, Okafor CJ, Obeagu GU, Ibekwe AM, Okpala 
PU, Agu CC. Assessment of Haematological Changes in Pregnant 
Women of Ido, Ondo State, Nigeria. J Res Med Dent Sci. 2021 
Apr;9(4):145-148. 

6. Agreen FC, Obeagu EI. Anaemia among pregnant women: A review 
of African pregnant teenagers. Journal of Public Health and 
Nutrition. 2023;6(1):138. 

7. Arora S, Rana D, Kolte S, Dawson L, Dhawan I. Validation of new 
indices for differentiation between iron deficiency anemia and 
beta thalessemia trait, a study in pregnant females. International 
Journal of Scientific Reports. 2018; 4(2):26. 
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20180394 

8. Obeagu EI, Obeagu GU, Insights into Maternal Health: Mentzer Index 
for Early Anemia Detection, International Journal of Medical 
Sciences and Pharma Research,2024;10(4):44-49 
https://doi.org/10.22270/ijmspr.v10i4.122 

9. Obeagu EI, Influence of Hemoglobin Variants on Vaso-Occlusive 
Phenomena in Sickle Cell Anemia: A Review, International Journal 
of Medical Sciences and Pharma Research, 2024;10(2):54-59 
https://doi.org/10.22270/ijmspr.v10i2.104 

10. Iolascon A, Andolfo I, Russo R, Sanchez M, Busti F, Swinkels D, 
Aguilar Martinez P, Bou‐Fakhredin R, Muckenthaler MU, Unal S, 
Porto G. Recommendations for diagnosis, treatment, and 
prevention of iron deficiency and iron deficiency anemia. 
Hemasphere. 2024; 8(7):e108. 
https://doi.org/10.1002/hem3.108 PMid:39011129 
PMCid:PMC11247274 

11. Obeagu EI, Obeagu GU, Chukwueze CM, Ikpenwa JN, Ramos GF. 
Evaluation of protein C, protein S and fibrinogen of pregnant 
women with malaria in Owerri metropolis. Madonna University 
journal of Medicine and Health Sciences ISSN: 2814-3035. 2022 
Apr 19;2(2):1-9. 

12. Obeagu EI, Obeagu GU. Neonatal Outcomes in Children Born to 
Mothers with Severe Malaria, HIV, and Transfusion History: A 
Review. Elite Journal of Nursing and Health Science, 2024; 2(3): 
38-58 

13. Sahli CA, Bibi A, Ouali F, Fredj SH, Dakhlaoui B, Othmani R, Laouini 
N, Jouini L, Ouenniche F, Siala H, Touhami I. Red cell indices: 
differentiation between β-thalassemia trait and iron deficiency 
anemia and application to sickle-cell disease and sickle-cell 
thalassemia. Clinical Chemistry and Laboratory Medicine (CCLM). 
2013; 51(11):2115-24. https://doi.org/10.1515/cclm-2013-0354 
PMid:23800659 

14. Hoffmann JJ, Nabbe KC, van den Broek NM. Effect of age and 
gender on reference intervals of red blood cell distribution width 
(RDW) and mean red cell volume (MCV). Clinical Chemistry and 
Laboratory Medicine (CCLM). 2015; 53(12):2015-9. 
https://doi.org/10.1515/cclm-2015-0155 PMid:26536583 

15. Miftahussurur M, Husada D, Ningtyas WS. Association Association 
Of Shine and Lal Index Β-Thalassemia Trait Screening Results with 
Anaemia and Low Birth Weigh. International Journal of Nursing 
And Midwifery Science (IJNMS). 2023; 7(3):290-296. 
https://doi.org/10.29082/IJNMS/2023/Vol7/Iss3/543 

16. Shahid H, Saleem M, Naseer N, Tabussam S, Aziz A, Ullah S. 
Evaluation of Srivastava index to distinguishing Beta-Thalassemia 
Trait from Iron Deficiency. Pakistan Journal of Medical & Health 
Sciences. 2022;16(05):1225. 
https://doi.org/10.53350/pjmhs221651225 

17. Vehapoglu A, Ozgurhan G, Demir AD, Uzuner S, Nursoy MA, 
Turkmen S, Kacan A. Hematological indices for differential 
diagnosis of Beta thalassemia trait and iron deficiency anemia. 
Anemia. 2014; 2014(1):576738. 
https://doi.org/10.1155/2014/576738 PMid:24818016 
PMCid:PMC4003757 

18. Urrechaga E. Discriminant value of% microcytic/% hypochromic 
ratio in the differential diagnosis of microcytic anemia. Clinical 
chemistry and laboratory medicine. 2008;46(12):1752-1758. 
https://doi.org/10.1515/CCLM.2008.355 PMid:19055451 

19. Obeagu EI, Obeagu GU, Anemia in Pregnancy: Mentzer Index as a 
Predictor for Iron Supplementation Needs, International Journal 
of Medical Sciences and Pharma Research, 2024;10(4):39-43 
https://doi.org/10.22270/ijmspr.v10i4.121 

20. Obeagu EI, Obeagu GU. Sickle cell anaemia in pregnancy: a review. 
International Research in Medical and Health Sciences. 2023 Jun 
10;6(2):10-13. https://doi.org/10.22270/ijmspr.v10i2.103 

21. Obeagu EI, Ubosi NI, Uzoma G. Antioxidant Supplementation in 
Pregnancy: Effects on Maternal and Infant Health. Int. J. Adv. 
Multidiscip. Res. 2023;10(11):60-70. 

22. Obeagu EI, Obeagu GU. Mitigating Oxidative Stress in Pregnancy 
through Antioxidant Supplementation: A Narrative Review. Int. J. 
Curr. Res. Chem. Pharm. Sci. 2024;11(9):7-17. 

23. Obeagu EI, Obeagu GU. Enhancing Maternal and Fetal Well-being: 
The Role of Antioxidants in Pregnancy. Elite Journal of Medical 
Sciences. 2024;2(4):76-87. 

24. Obeagu EI, Obeagu GU. Antioxidant Supplementation and 
Prevention of Early Pregnancy Loss: A Narrative Review. Int. J. 
Curr. Res. Chem. Pharm. Sci. 2024;11(9):28-37. 
https://doi.org/10.22270/ijmspr.v10i4.120 

25. Obeagu EI, Obeagu GU. Molar Pregnancy: Update of prevalence and 
risk factors. Int. J. Curr. Res. Med. Sci. 2023;9(7):25-28. 
https://doi.org/10.19080/JGWH.2023.25.556169 

26. Obeagu EI, Obeagu GU. Hypoxia-induced Metabolic Changes in 
Pregnancy: Clinical Perspectives. Elite Journal of Medicine. 
2024;2(8):50-59. 

27. Obeagu EI, Obeagu GU. Hemolysis Challenges for Pregnant Women 
with Sickle Cell Anemia: A Review. Elite Journal of Haematology. 
2024;2(3):67-80.

 

https://doi.org/10.3945/ajcn.115.107896
https://doi.org/10.22270/ijmspr.v10i2.95
https://doi.org/10.2147/IJWH.S89308
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20180394
https://doi.org/10.22270/ijmspr.v10i4.122
https://doi.org/10.22270/ijmspr.v10i2.104
https://doi.org/10.1002/hem3.108
https://doi.org/10.1515/cclm-2013-0354
https://doi.org/10.1515/cclm-2015-0155
https://doi.org/10.29082/IJNMS/2023/Vol7/Iss3/543
https://doi.org/10.53350/pjmhs221651225
https://doi.org/10.1155/2014/576738
https://doi.org/10.1515/CCLM.2008.355
https://doi.org/10.22270/ijmspr.v10i4.121
https://doi.org/10.22270/ijmspr.v10i2.103
https://doi.org/10.22270/ijmspr.v10i4.120
https://doi.org/10.19080/JGWH.2023.25.556169

